MANAMA – Bahrain’s approval of the Pfizer / BioNTech coronavirus vaccine makes the state the second country in the world to be granted the ‘Autonomous Use’ Authority (EUA) for vaccines.
Confirmation of approval by Bahrain’s National Health Regulatory Authority (NHRA), in-depth analysis and review by the authority of all available data. This is the second approval of Bahrain’s COVID-19 vaccine EUA, following state approval in November of the Sinopharma vaccine for use by frontline activists.
Also Read: Saudi Arabia committed to global efforts to combat COVID-19: Foreign minister
Bahrain’s comprehensive “Test, Trace and Treat” COVID-19 response strategy has one of the highest per capita test rates in the world, proven to be effective in breaking infection chains, managing case numbers and saving lives. happened.
Dr. Maryam Al Jalahama, CEO of NHRA commented: “The approval of the Pfizer / Bioentech vaccine will add another important layer to Saudi’s national COVID-19 response, which has improved the health of all citizens and residents during M’hama’ari Defense is given priority. . ”
Lindsay Ditsky, Pfizer Gulf Cluster Lead, said: “Today’s Bahrain marked a historic moment in the fight against the ‘utilitarian’ green use authority COVID-19 in Saudi Arabia.”
Also Read: Bahrain becomes second country to allow Pfizer-BioNTech vaccine
“This authority is a goal we are working towards since we first announced that science will prevail, and we applaud the National Health Regulatory Authority in the state of Bahrain for carefully assessing and helping protect people Take timely action for
